SARS-CoV-2-linked hospitalization, ED encounters rare after Paxlovid

SARS-CoV-2-linked hospitalization, ED encounters rare after paxlovid

Hospitalization and emergency department encounters related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occur rarely during the five to 15 days after Paxlovid treatment is dispensed for mild-to-moderate COVID-19, according to research published in the June 24 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Deborah E. Malden, D.Phil., from the CDC in Atlanta, and colleagues used electronic health record data from Kaiser Permanente Southern California to describe and emergency department encounters related to SARS-CoV-2 infections during the five to 15 days after a five-day course of Paxlovid. Of the 5,287 persons aged ≥12 years who received Paxlovid during Dec. 31, 2021, to May 26, 2022, 73 and 8 percent had received three or more doses of COVID-19 vaccine and were unvaccinated, respectively.

The researchers identified six hospitalizations and 39 emergency department encounters considered related to SARS-CoV-2 infection during the five to 15 days after Paxlovid treatment was dispensed, representing <1 percent of all patients to whom Paxlovid was dispensed. Of these 45 patients, 47 percent were aged ≥65 years and 78 percent had one or more underlying conditions.

"When administered as an early-stage treatment, Paxlovid might prevent COVID-19-related hospitalization among persons with mild-to-moderate COVID-19 cases who are at risk for progression to severe disease," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Pfizer, the manufacturer of Paxlovid.

More information: Deborah E. Malden et al, Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment—California, December 2021–May 2022, MMWR. Morbidity and Mortality Weekly Report (2022). DOI: 10.15585/mmwr.mm7125e2

Copyright © 2022 HealthDay. All rights reserved.

Citation: SARS-CoV-2-linked hospitalization, ED encounters rare after Paxlovid (2022, June 29) retrieved 26 May 2024 from https://medicalxpress.com/news/2022-06-sars-cov-linked-hospitalization-ed-encounters-rare.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Vaccine effectiveness lower for teens with predominant omicron

3 shares

Feedback to editors